Astria Therapeutics Inc
(ATXS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2014 | 12-2013 | 12-2006 | 12-2005 | |
| Cash Flows From Operating Activities | ||||
| Net Income | -21,884 | -18,118 | N/A | N/A |
| Depreciation Amortization | 248 | 320 | N/A | N/A |
| Accounts payable and accrued liabilities | 481 | -129 | N/A | N/A |
| Other Working Capital | 253 | 1,089 | N/A | N/A |
| Other Operating Activity | 490 | 472 | 0 | 0 |
| Operating Cash Flow | $-20,412 | $-16,366 | $N/A | $N/A |
| Cash Flows From Investing Activities | ||||
| PPE Investments | -228 | -43 | N/A | N/A |
| Purchase Of Investment | -4,976 | N/A | N/A | N/A |
| Sale Of Investment | 4,976 | N/A | N/A | N/A |
| Investing Cash Flow | $-228 | $-43 | $N/A | $N/A |
| Cash Flows From Financing Activities | ||||
| Debt Issued | 5,000 | N/A | N/A | N/A |
| Common Stock Issued | 118 | 27 | N/A | N/A |
| Other Financing Activity | -284 | 41,422 | 0 | 0 |
| Financing Cash Flow | $4,834 | $41,449 | $N/A | $N/A |
| Beginning Cash Position | 30,474 | 5,434 | N/A | N/A |
| End Cash Position | 14,668 | 30,474 | N/A | N/A |
| Net Cash Flow | $-15,806 | $25,040 | $N/A | $N/A |
| Free Cash Flow | ||||
| Operating Cash Flow | -20,412 | -16,366 | N/A | N/A |
| Capital Expenditure | -228 | -43 | N/A | N/A |
| Free Cash Flow | -20,640 | -16,409 | 0 | 0 |